Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-02
2011-08-02
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S576000, C540S578000, C540S580000, C540S586000
Reexamination Certificate
active
07989444
ABSTRACT:
Compounds of formula (I)wherein A is a 5 or 6 membered heteroaromatic ring or a 5 or 6 membered heterocyclic ring, and which are useful for treating mental disorders such as schizophrenia are set out herein.
REFERENCES:
patent: 27 51 258 (1978-06-01), None
patent: WO 94/20472 (1994-09-01), None
patent: WO 00/42036 (2000-07-01), None
patent: WO 02/40471 (2002-05-01), None
Bonanomi Giorgio
Damiani Federica
Gentile Gabriella
Hamprecht Dieter Wolfgang
Micheli Fabrizio
Coleman Brenda
Deppenbrock Bonnie L.
Glaxo Group Limited
LandOfFree
Compounds having affinity for dopamine D3 receptor and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having affinity for dopamine D3 receptor and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having affinity for dopamine D3 receptor and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2791929